Innovent Biologics Inc.
IVBXF | OTC
$9.90
-$1.40 (-12.39%)
At close: Oct 30, 2026, 2:35 PM ET
$11.54
+$1.64 (+16.57%)
Pre-market:
Nov 2, 2026, 8:05 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 17.35B | 7.51B | 10.05B | 1.02B | 1.36B | 1.28B |
Short-Term Investments | 887.12M | 375.56M | 867.53M | 7.25B | 6.58B | 6.77B |
Long-Term Investments | 7.89B | 3.9B | 794.09M | 630.2M | -6.16B | -6.76B |
Other Long-Term Assets | 471.34M | 499.02M | 1.72B | 193.06M | 6.71B | 6.91B |
Receivables | 1.75B | 1.57B | 1.01B | 911.79M | 1.18B | 639.89M |
Inventory | 1.3B | 822.17M | 968.09M | 1.43B | 1.35B | 705.66M |
Other Current Assets | 729.38M | n/a | 484.38M | 901.44M | 6.64M | n/a |
Total Current Assets | 22.02B | 10.27B | 13.43B | 11.51B | 11.55B | 9.47B |
Property-Plant & Equipment | 5.44B | 5.65B | 4.66B | 4.06B | 3.38B | 2.18B |
Goodwill & Intangibles | 1.53B | 1.28B | 27.79M | 1.2B | 772.19M | 32.63M |
Total Long-Term Assets | 15.34B | 11.33B | 7.2B | 6.08B | 4.69B | 2.37B |
Total Assets | 37.36B | 21.6B | 20.63B | 17.59B | 16.24B | 11.83B |
Account Payables | 494.8M | 357.68M | 372.55M | 325.62M | 195.05M | 120.62M |
Deferred Revenue | 2.31B | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 800.54M | 405.1M | 1.2B | 888M | 365M | 255M |
Other Current Liabilities | 4.77B | 2.32B | 728.33M | 741.92M | 790.15M | 274.13M |
Total Current Liabilities | 8.39B | 4.37B | 4.48B | 3.5B | 3.05B | 1.49B |
Long-Term Debt | 1.99B | 2.41B | 2.33B | 2.22B | 2.02B | 925.18M |
Other Long-Term Liabilities | 643.29M | 1.7B | 262.71M | 162.31M | 342K | 633.96M |
Total Long-Term Liabilities | 8.81B | 4.12B | 3.62B | 3.36B | 2.86B | 1.57B |
Total Liabilities | 17.2B | 8.48B | 8.1B | 6.86B | 5.91B | 3.06B |
Total Debt | 2.82B | 2.83B | 3.62B | 3.23B | 2.5B | 1.21B |
Book Value | 20.16B | 13.12B | 12.53B | 10.73B | 10.33B | 8.78B |
Book Value Per Share | 11.58 | 8.06 | 8.03 | 7.20 | 7.10 | 6.47 |
Common Stock | 119.05K | 113K | 112K | 105K | 101K | 97K |
Retained Earnings | -15.09B | -15.91B | -15.77B | -14.74B | -12.56B | -9.98B |
Comprehensive Income | 1.55B | 1.3B | 970.54M | 763.86M | 397.02M | 220.41M |
Shareholders Equity | 19.36B | 13.12B | 12.53B | 10.73B | 10.33B | 8.78B |
Total Investments | 8.78B | 4.28B | 1.66B | 7.88B | 417.26M | 12.94M |
Add to Watchlist
Select watchlists to add or remove IVBXF